• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α1肾上腺素能受体亚型在良性前列腺增生中的作用——从临床到实验室研究

[The role of alpha1-adrenoceptor subtypes in benign prostatic hyperplasia-from bed to bench].

作者信息

Kojima Yoshiyuki, Hayase Masa, Imura Makoto, Okada Shinsuke, Kubota Yasue, Sasaki Shoichi, Hayashi Yutaro, Kohri Kenjiro

机构信息

Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences.

出版信息

Hinyokika Kiyo. 2008 Jun;54(6):457-62.

PMID:18634446
Abstract

Alpha 1-adrenoceptors (alpha1-ARs) play a role in the regulation of prostatic smooth muscle tone, and are critical mediators of lower urinary tract symptoms (LUTS) and pathophysiology in benign prostatic hyperplasia (BPH). Three subtypes (alpha1a, alpha1b, alpha1d) have been identified by molecular cloning techniques. Although the reasons for the existence of three subtypes remain elusive, recent findings suggest a role of subtype and tissue-specific regulation. We examined the role of each alpha1-AR-subtype in the prostate to apply some new findings obtained from basic research for the clinical treatment. We have demonstrated that the mRNA expression levels of alpha1-AR-subtypes in the prostate differed among patients and that the genetic background differences of patients with BPH were responsible for the diverse responses to subtype-selective alpha1-blockers. In addition, both alpha1a- and alpha1d-AR-subtypes play a significant role in the spontaneous contraction of human prostate and, especially alpha1d-AR-subtypes may also control the cell growth of the prostate. Clarification of the mechanism of alpha1-AR subtypes in the prostate will provide more effective therapy for BPH patients.

摘要

α1肾上腺素能受体(α1-ARs)在前列腺平滑肌张力调节中发挥作用,并且是良性前列腺增生(BPH)患者下尿路症状(LUTS)及病理生理学的关键介质。通过分子克隆技术已鉴定出三种亚型(α1a、α1b、α1d)。尽管三种亚型存在的原因仍不明确,但最近的研究结果表明存在亚型及组织特异性调节作用。我们研究了每种α1-AR亚型在前列腺中的作用,以便将基础研究中获得的一些新发现应用于临床治疗。我们已经证明,前列腺中α1-AR亚型的mRNA表达水平在患者之间存在差异,并且BPH患者的遗传背景差异是对亚型选择性α1阻滞剂产生不同反应的原因。此外,α1a和α1d-AR亚型在人前列腺的自发收缩中均起重要作用,尤其是α1d-AR亚型可能还控制着前列腺的细胞生长。阐明前列腺中α1-AR亚型的机制将为BPH患者提供更有效的治疗方法。

相似文献

1
[The role of alpha1-adrenoceptor subtypes in benign prostatic hyperplasia-from bed to bench].α1肾上腺素能受体亚型在良性前列腺增生中的作用——从临床到实验室研究
Hinyokika Kiyo. 2008 Jun;54(6):457-62.
2
History and nomenclature of alpha1-adrenoceptors.α1肾上腺素能受体的历史与命名
Eur Urol. 1999;36 Suppl 1:2-6.
3
Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate.α1A-1、α1B和α1D肾上腺素能受体在增生性和非增生性人前列腺中的定位与表达
J Urol. 1999 Feb;161(2):635-40.
4
Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia.α1-肾上腺素能受体亚型mRNA的表达作为亚型选择性α1-肾上腺素能受体拮抗剂治疗良性前列腺增生疗效的预测指标。
J Urol. 2008 Mar;179(3):1040-6. doi: 10.1016/j.juro.2007.10.082. Epub 2008 Jan 18.
5
Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.亚型选择性α(1) -肾上腺素能受体拮抗剂萘哌地尔对良性前列腺增生中前列腺生长的抑制作用
Prostate. 2009 Oct 1;69(14):1521-8. doi: 10.1002/pros.21003.
6
Change of expression levels of alpha1-adrenoceptor subtypes by administration of alpha1d-adrenoceptor-subtype-selective antagonist naftopidil in benign prostate hyperplasia patients.在良性前列腺增生患者中,通过给予α1d-肾上腺素能受体亚型选择性拮抗剂萘哌地尔改变α1-肾上腺素能受体亚型的表达水平。
Prostate. 2007 Sep 1;67(12):1285-92. doi: 10.1002/pros.20624.
7
Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists.α-肾上腺素能受体与良性前列腺增生:α-肾上腺素能受体拮抗剂治疗的基本原理
World J Urol. 2002 Apr;19(6):390-6.
8
Quantification of alpha1-adrenoceptor subtypes by real-time RT-PCR and correlation with age and prostate volume in benign prostatic hyperplasia patients.通过实时逆转录聚合酶链反应对良性前列腺增生患者α1-肾上腺素能受体亚型进行定量分析及其与年龄和前列腺体积的相关性研究。
Prostate. 2006 May 15;66(7):761-7. doi: 10.1002/pros.20399.
9
Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.在良性前列腺增生症患者中,给予亚型选择性α1-肾上腺素受体拮抗剂坦索罗辛可上调前列腺中的α1a 和α1d-肾上腺素受体。
J Urol. 2011 Oct;186(4):1530-6. doi: 10.1016/j.juro.2011.05.048. Epub 2011 Aug 19.
10
Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia.α1肾上腺素能受体及其抑制剂在膀胱过度活动症和良性前列腺增生中的作用
J Urol. 2004 Mar;171(3):1029-35. doi: 10.1097/01.ju.0000097026.43866.cc.